4. Maternal–fetal interface

The maternal–fetal interface is established through coordinated differentiation of trophoblast lineages and reciprocal interactions with decidual stromal and immune cells that regulate placental development, vascular remodeling, and immune homeostasis. Villous cytotrophoblast progenitors proliferate and differentiate either by cell fusion into multinucleated syncytiotrophoblast, which mediates nutrient exchange and endocrine activity, or into extravillous trophoblast (EVT), which undergoes epithelial-to-mesenchymal-like differentiation during acquisition of an invasive phenotype. EVT differentiation and invasion are regulated by integrated signaling networks, including WNT/β-catenin, TGF-β/SMAD, Notch, Hippo–YAP/TAZ, PI3K–AKT, and oxygen-sensitive HIF pathways, together with coordinated extracellular matrix remodeling involving MMP2, MMP9, membrane-associated matrix metalloproteinases, additional protease systems, their tissue inhibitors (TIMPs), integrin switching, and local growth factor signaling.

A defining feature of trophoblast invasion is the specialized immune dialogue between EVT and decidual immune cells. EVTs express the non-classical major histocompatibility complex molecule HLA-G together with HLA-C, whereas classical HLA-A and HLA-B are absent. HLA-G engages inhibitory receptors including LILRB1 and LILRB2, while interactions involving KIR2DL4 remain incompletely resolved. HLA-C allotypes interact with activating and inhibitory maternal killer-cell immunoglobulin-like receptors (KIRs) expressed by decidual natural killer (dNK) cells. Maternal KIR and fetal HLA-C genetic combinations influence dNK activation, trophoblast invasion, and uterine vascular remodeling, with altered receptor–ligand interactions associated with impaired placentation. Rather than mediating cytotoxicity, dNK cells secrete angiogenic and immunoregulatory factors that support EVT migration and cooperate with invading trophoblasts, macrophages, and vascular cells during spiral artery remodeling, whereas decidual macrophages contribute to extracellular matrix remodeling, apoptotic cell clearance, and immune regulation.

Immune tolerance at the maternal–fetal interface is reinforced by decidual stromal cell differentiation and local immunoregulatory networks. Decidual stromal cells remodel the extracellular matrix, regulate leukocyte trafficking, and produce cytokines and chemokines that shape immune cell function. TGF-β and IL-10 suppress inflammatory responses while promoting regulatory immune phenotypes, whereas indoleamine 2,3-dioxygenase (IDO) depletes tryptophan and generates kynurenine metabolites that inhibit effector T-cell activation and favor immune tolerance. These pathways act cooperatively with HLA-G-dependent signaling and additional immune checkpoint mechanisms, including PD-L1 and CD39/CD73 signaling, to maintain fetal tolerance while preserving antimicrobial defense.

Successful placentation also depends on tightly regulated placental angiogenesis and uteroplacental vascular remodeling. VEGF-A signals through VEGFR1 (FLT1) and VEGFR2 (KDR), whereas placental growth factor (PlGF) binds primarily to VEGFR1, coordinating endothelial proliferation, vascular branching, and vascular remodeling. Balanced angiogenic signaling integrates trophoblast invasion with uteroplacental vascular development, whereas dysregulated VEGF/PlGF pathways are strongly associated with placental insufficiency and preeclampsia.

Current mechanistic studies integrate complementary experimental platforms. Primary human first-trimester trophoblast isolation, trophoblast organoids, and three-dimensional placental culture systems reproduce lineage differentiation and invasion in vitro. Single-cell RNA sequencing and spatial transcriptomics of first-trimester decidua and chorionic villi resolve trophoblast, stromal, endothelial, dNK, macrophage, and other immune cell populations together with their ligand–receptor interactions. Flow cytometry characterizes decidual immune cell subsets, multiplex immunofluorescence and imaging mass cytometry localize HLA-G, HLA-C, and additional lineage markers within placental tissues, ELISA and multiplex cytokine assays quantify TGF-β, IL-10, PlGF, and VEGF, and CRISPR–Cas9 or siRNA-mediated perturbation of invasion-associated genes defines molecular regulators of EVT differentiation, extracellular matrix remodeling, and maternal–fetal communication.